Use of foam form of 3% Ethoxysclerol in the venous malformations treatment of the maxillofacial region
This article describes the experience of treating 60 patients with venous malformations of the maxillofacial region with a foam form of ethoxysclerol. The possibilities of application were studied and the expediency of using this method of treatment was justified. Based on the data of the clinical examination and the results of the ultrasound examination, the volume of the injected sclerosant in the foam form, the tactics, and the method of optimal surgical treatment were determined. Clinical observations, confirmed by ultrasound data, showed the significant difference in criteria of assessment only for involved zone amount (p<.05), and the effectiveness of sclerosing treatment method with 3% ethoxysclerol for the venous malformations of the maxillofacial region: for small, average, and huge focus of malformation, the significant decrease in size was observed after 14 and 30 days (p< .001). Thus, the 3% ethoxysclerol can be recommended for use in maxillofacial surgery for the treatment of all venous malformations.
Contact SPER Publications
SPER Publications and Solutions Pvt. Ltd.
HD - 236,
Near The Shri Ram Millenium School,
Noida-Greater Noida Expressway,
Noida-201301 [Delhi-NCR] India